Ellison Institute to develop the 5.9-acre site, which will include laboratories and offices
OXFORD, U.K. – DECEMBER 9, 2021 – The Lawrence J. Ellison Institute for Transformative Medicine strengthened its ongoing partnership with the University of Oxford and the Tony Blair Institute for Global Change with the purchase of a prime life science property in Oxford.
The Ellison Institute acquired the 5.9-acre site which includes the 41,417 sq. ft. Littlemore House. Plans call for two additional buildings to house research laboratories and additional collaborative spaces in support of the consortium’s vaccine research, scientific data collection, and work in the development sector.
A future hub of the Global Health Security Consortium and other Ellison Institute projects, the property is strategically located next to The Oxford Science Park, and was purchased from London-based Charterhouse Property Group.
“We are thrilled to expand our footprint and create a first-class home for the pathbreaking work that the Ellison Institute and the Consortium, its leaders, and researchers are doing to improve human lives and help to keep humanity safe,” said Dr. David Agus, founding director of the Ellison Institute.
Added Sir John Bell, “Bringing together the Ellison Institute’s cutting-edge approach to innovation and Oxford’s deep expertise in life sciences will unlock tremendous potential to improve human health.”
Michael Holt, Charterhouse CEO stated, “We are delighted to be selling the property to the Ellison Institute and to support their vision to be at the cutting edge of life science research and disease prevention. Our company is concerned that R&D and laboratory accommodation is in extremely short supply in Oxford. We believe that emerging planning policy in Oxford should continue to work with world class companies and institutes to ensure Oxford continues to be at the forefront of innovation in this sector.”
The acquisition marks the first property purchase by the Ellison Institute in the UK market.
Drawing on its expertise in science, medicine, and policy, the aim of the Global Health Security Consortium, formally launched in May, is to provide insight, analysis, and support for leaders around the world to help them understand today’s pandemic and prepare for health security challenges of tomorrow. As one of its flagship projects, the Consortium led the strategic launch of the Global Pathogen Analysis System (GPAS), a cloud-based solution developed by Oxford scientists for SARS-CoV-2 genomic epidemiology and early warning systems.
“We will always look to push the boundaries of what is politically and scientifically possible but also commit to presenting clear and actionable roadmaps that leaders can put to use,” Dr. Agus and former UK Prime Minister Tony Blair said at the time. “Our aim is to help turn ideas into reality that changes lives for the better.”
The Ellison Institute was advised on the property acquisition by Trowers and Hamlins LLP, led by real estate partner Tom Calnan, and by Hicks Baker, as real estate consultant, led by Stephen Head. Charterhouse was advised by Memery Crystal, ACRE and Savills.
Email: [email protected]
Phone: + 01 (310) 228-6400
About the Lawrence J. Ellison Institute for Transformative Medicine
The Ellison Institute tackles difficult questions in healthcare and medical research to push the boundaries of medicine. We offer multifaceted programs, including a cancer clinic, cross-disciplinary research laboratories, a health policy think-tank, and community outreach and educational programs at our Institute.
About the Tony Blair Institute for Global Change
The Tony Blair Institute supports political leaders and governments to build open, inclusive and prosperous societies in a globalized world. We do this through developing policy and advising governments.
About Charterhouse Property Group
Charterhouse is a private property investment and development company founded in 1994. The business focuses on adding value through active asset management, planning, and development. Charterhouse Property Group’s opportunity-based approach has facilitated the company’s growth, diversifying over time to invest in a broad range of commercial and residential sectors.